301688.SZ
C格林生物
SZSE · C 制造业 · CN
CNY 41.19
Margins
Gross margin
30.1%
EBITDA margin
24.8%
EBIT margin
18.2%
Net margin
16.1%
FCF margin
6.2%
21.5%
Return on equity
9.8%
Return on assets
13.1%
Return on invested capital
0.61x
Asset turnover
CNY 158.5M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026